Molecular Pathogenesis and New Interventions in Scleroderma: Request for Applications (RFA)
The Scleroderma Research Foundation's RFA supports innovative research into the molecular mechanisms and novel interventions for scleroderma, encouraging cross-disciplinary and translational science.
Funder: Scleroderma Research Foundation
Due Dates (Anticipated): February 2027 (application deadline, projected) | March 2027 (new grants/full application deadline, projected)
Funding Amounts: Investigator-Initiated: up to $200,000/year (up to 3 years); Exploratory/Developmental & New Faculty: up to $75,000/year (up to 2 years); no overhead/indirects.
Summary: Supports research into the molecular mechanisms and innovative therapies for scleroderma, encouraging cross-disciplinary and translational projects.
Key Information: Grant recipients must attend the annual SRF Workshop to present their research.
Description
This program from the Scleroderma Research Foundation aims to advance understanding of the molecular and cellular mechanisms underlying scleroderma, with the ultimate goal of developing new diagnostic tools and therapeutic interventions. The RFA encourages both established and new investigators to pursue hypothesis-driven, innovative research that addresses immune dysregulation, fibrosis, vascular abnormalities, genomic factors, biomarkers, and translational approaches for scleroderma and its complications. The initiative places a strong emphasis on collaboration across disciplines and institutions, attracting new talent to the field, and introducing novel technologies to accelerate progress in scleroderma research.
